Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Rituximab 375 mg/m(2) weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura. Overall (platelet count > 50 x 10(9)/L) and comple...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, S. Palmieri, Marco Montagna, Nicola Vianelli, L. Marin, M. Cavallin, Monica Bocchia, Marzia Defina, M. Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin
Médium: Artigo
Jazyk:angličtina
Vydáno: 2008
On-line přístup:https://doi.org/10.3324/haematol.12206
https://haematologica.org/article/download/4889/19734
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.3324/haematol.12206
https://haematologica.org/article/download/4889/19734

Podobné jednotky